Kate Parker

Kate Parker is an experienced professional in health research management and ethics, currently serving as the Lung Cancer Screening Research Manager at Waitematā District Health Board since February 2020. Concurrently, Kate is a Committee Member of the Health and Disability Ethics Committee (HDEC) Northern A. Prior roles include Programme Manager for the NETwork! initiative at The University of Auckland and Director of Operations at Proacta Therapeutics Ltd. Kate has also contributed as a Consultant and Contracts Manager at Auckland UniServices Limited, and held various positions at Glaxo SmithKline and CMR International. Kate holds a PhD in Pharmacy from Cardiff University, an MSc in Clinical Pharmacology from the University of Aberdeen, and a BSc in Pharmacology and Physiology from the University of Leeds.